Physician profile
Mark J Gettleman
NPI 1801989611
$530.76
in general payments reported to CMS, 2019-2025
9 companies · $67.14 in 2025
The $67.14 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78.20 · 2020: $14.06 · 2021: $89.66 · 2022: $46.71 · 2023: $166 · 2024: $69.28 · 2025: $67.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $302.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $110.21 | 2021-2025 | Gardasil 9, M-M-R II, Vaxneuvance |
| Pfizer INC. | $99.61 | 2019-2024 | |
| Cranial Technologies, INC | $92.77 | 2023-2025 | Doc Band |
| Sanofi Pasteur INC. | $68.76 | 2022-2025 | |
| Sobi, INC | $48.63 | 2019-2023 | |
| Corium, LLC | $46.00 | 2022-2024 | Azstarys |
| Ironshore Pharmaceuticals INC. | $33.91 | 2019 | |
| Adlon Therapeutics L.P. | $16.81 | 2021 | |
| Genentech USA, INC. | $14.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Gettleman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.